[Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000812:Anhydrides / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000812:Anhydrides; D000970:Antineoplastic Agents; D003561:Cytarabine